Verona Pharma’s Post

View organization page for Verona Pharma, graphic

15,527 followers

3mo

The #FDAApproval of the first inhaled product with a novel mechanism of action for the maintenance treatment of #COPD in over 20 years represents an important advancement for the COPD community. Thank you to all those involved in our clinical trials, and the Verona team for their support, participation and collaboration! More: https://bit.ly/4bnUSxt

11 Comments

David Ebsworth

3mo

My congratulations and thanks go to all on the Verona Team for all your efforts to bring this new therapeutic option to patients. It has been an honour to lead the board for the past nine years and support your efforts! David

8 Reactions

Steven Brown

Medical-Legal Consultations in Pulmonary, Critical Care, and Sleep Medicine

3mo

I spoke on ensifentrine to a group of over a hundred primary care providers, while lecturing on COPD, last week. There was genuine interest and enthusiasm. And many questions. Several more lectures are planned. Please ask your medical liaison to connect. I will also be in Boston at CHEST2024.

David Pham, MD, FCCP

Immunologist, Pulmonologist, Educator, Academia, Telehealth Expert, Entrepreneur and practitioner of IKIGIA, Healthcare policy to improve access of health

3mo

Congrats to the Verona team. The future of inhaled PD4/5 inhibition in COPD and possibly its role in reducing mucus production through goblet cell cell effects.

1 Reaction

Amelia Elizabeth Rose

| Building a Global Talent Solutions Revolution | Executive Pharmaceutical Headhunter | Vector |

3mo

Huge Congratulations Chris M. and Verona Team This is going to completely change the field for COPD patients, and I can't to see this pass EMA regulations as well. I know people close to me who are affected, and your dual inhibitor could be incredible for their lives. So thank you 😊

Afssaneh Rahbar

Senior Strategic Consultant for Pharmaceutical Industry

3mo

Congrats to you and the Verona team! 👏🏼 I was just recently at the ATS and attended the Verona presentations. Very impressed! Good luck for the team. 🍀

Debbie Randle

Pharmaceutical Sales Professional with experience in multiple fields.

3mo

Congrats! I want to work for you

Kristin Wooden

Pfizer Vaccines Health and Science Specialist

3mo

Well done!

Eden Jenkins

Amneal Pharmaceuticals

3mo

Exciting times!

Jan Willem Mooren (CTO)

Fixing data center operations

3mo

Congrats!

See more comments

To view or add a comment, sign in

More Relevant Posts

PRIME Education

3,231 followers
1mo
Report this post
Test your abilities and see how your choices compare with those of your peers in this Clinical Case Challenge | Navigating COPD Classification and Treatment Selection in Accordance With the Latest Evidence and Guidelines | #MedEd #cme #COPD | https://bit.ly/3WDnj6X
Like Comment
To view or add a comment, sign in
PRIME Education

3,231 followers
3w
Report this post
Test your abilities and see how your choices compare with those of your peers in this Clinical Case Challenge | Navigating COPD Classification and Treatment Selection in Accordance With the Latest Evidence and Guidelines | #MedEd #cme #COPD | https://bit.ly/3WDnj6X
Like Comment
To view or add a comment, sign in
PRIME Education

3,231 followers
2mo
Report this post
Test your abilities and see how your choices compare with those of your peers in this Clinical Case Challenge | Navigating COPD Classification and Treatment Selection in Accordance With the Latest Evidence and Guidelines | #MedEd #cme #COPD | https://bit.ly/3WDnj6X
Like Comment
To view or add a comment, sign in
Monaghan Medical Corporation

7,493 followers
1mo
Report this post
The AEROBIKA® OPEP device offers a clinically-proven, drug-free solution to support your COPD patients. By generating positive pressure and oscillations during exhalation, the AEROBIKA® OPEP device aids in clearing mucus and improving lung function. Studies demonstrate a 28% reduction in exacerbations¹, leading to fewer hospital visits and significant healthcare savings2. Daily use of the AEROBIKA® OPEP device has also been shown to improve patients' quality of life and increase lung capacity3. Consider adding the AEROBIKA® device to your COPD management plan to help your patients breathe easier and live better. #COPDManagement #RespiratoryCare #AskForAEROBIKA References: 1. Burudpakdee C, et al. Pulm Ther 2017;3(1):163–171. 2. Khoudigian-Sinani S, et al. Int J COPD 2017;12:3065-3073. 3. Svenningsen S. et al. COPD 2016;13(1):66 – 74.
Like Comment
To view or add a comment, sign in
PRIME Education

3,231 followers
3mo
Report this post
Test your abilities and see how your choices compare with those of your peers in this Clinical Case Challenge | Navigating COPD Classification and Treatment Selection in Accordance With the Latest Evidence and Guidelines | #MedEd #cme #COPD | https://bit.ly/3WDnj6X
Like Comment
To view or add a comment, sign in
Pulmonx Corporation

16,659 followers
2mo
Report this post
Lung volume reduction (LVR) is a clinically proven and recommended therapy for reducing breathlessness in advanced COPD. Changes in treatment mean that minimally invasive options such as endobronchial valves, are now available, but the majority of eligible patients are not referred. Gain a deeper understanding of the assessment and treatment with endobronchial valves for LVR via this on-demand webinar ➡️ https://bit.ly/3WZ7nMb #COPD #emphysema #Pulmonx #ZephyrValves #DigitalLearning This is a non-Pulmonx link. Webinar sponsored by Pulmonx Corporation. Results may vary.
Like Comment
To view or add a comment, sign in
Robert Fishwick MSHCM, RRT-NPS, C-NPT, COPD-E

Respiratory Care Manager @ Saint Jospeh’s Hospital | MS Health Care Admin
6mo Edited
Report this post
Watch Dr Whittles lecture. Maskless NIV is equivalent at CO2 reduction when compared to mask NIV and clearly superior in patient comfort to mask NIV. The data speaks for itself.

Vapotherm UK

1,306 followers
6mo

Discover how high velocity therapy could be a game-changer for COPD patients. Watch as Dr Jessica Whittle presents the #HYPERACT study findings detailing how this innovative approach might reduce the need for invasive ventilation methods in those patients with moderate to severe COPD. https://hubs.ly/Q02qWjfB0

Presenting HYPERACT - Vapotherm
Like Comment
To view or add a comment, sign in
Pulmonx Corporation

16,659 followers
4mo
Report this post
Watch this on-demand webinar on endobronchial valves as a treatment option for severe COPD/emphysema patients. Dive into each of the interactive seminar modules to learn more about: Part 1 - The multidimensional management of patients with severe COPD Part 2 - Lung Volume Reduction for COPD Part 3 - Assessment of patients and treatment with endobronchial valves Part 4 - Which patients are good candidates for endobronchial valves Part 5 - Patient Case Studies Access ➡️ https://bit.ly/3WZ7nMb #COPD #emphysema #Pulmonx #ZephyrValves #DigitalLearning This is a non-Pulmonx link. Webinar sponsored by Pulmonx Corporation. Results may vary.
Like Comment
To view or add a comment, sign in
Pulmonx Corporation

16,659 followers
3w Edited
Report this post
When assessing severe COPD/emphysema patients, the Chartis Precision Catheter helps predict likely responders to Zephyr Valves. With the new Chartis Precision Catheter, physicians can perform an easier assessment of the desired airway, regardless of diameter and length.* Learn more: https://bit.ly/4e2hSnH *Data on file #ZephyrValves #BLVR #MedDevice

The New Chartis Precision Catheter
Like Comment
To view or add a comment, sign in
Pulmonx Corporation

16,659 followers
6mo Edited
Report this post
In the latest Medscape clinician handbook and CME activity, learn how to identify potential candidates for endobronchial valve treatment and how it can improve quality of life for severe COPD/emphysema patients. https://bit.ly/3THFGp3 #Medscape #BLVR #Pulmonology
Like Comment
To view or add a comment, sign in

15,527 followers

View Profile Follow

Verona Pharma’s Post

More Relevant Posts

The New Chartis Precision Catheter

Explore topics